Market Research Logo

Asia Pacific Stem Cell Market Forecast 2018-2026

Asia Pacific Stem Cell Market Forecast 2018-2026

KEY FINDINGS

The Asia-Pacific stem cell market is anticipated to rise with the fastest CAGR of 10.13% over the projected years of 2018-2026. Chronic diseases like cancers have seen a considerable rise in the Asia-Pacific region. As a result, the demand for stem cell market is further expected to rise in this region.

MARKET INSIGHTS

The China stem cell market contributed the highest revenue share in 2017. A growing elderly population and fundamental progress in clinical stem cell research are factors which are majorly driving this country’s growth. The other countries analyzed in this report include India, Japan, South Korea and a few others in the rest of Asia-Pacific. Among these, a significant growth is expected from the Japan stem cell market. Japan currently plays a significant role in the cancer stem cells market in the Asia-Pacific region and the Japanese government is heavily investing in the healthcare industry in order to improve the healthcare facilities in the country.

COMPETITIVE INSIGHTS

Some of the leading players in this market are Stemedica Cell Technologies Inc, Cellular Engineering Technologies Inc, Biotime Inc, Kangstem Biotech Ltd, Becton Dickinson, Cytori Therapeutics, Cellular Dynamics International (Holding Company Fujifilm), Thermo Fisher Vericel Corporation, Fibrocell Science Inc, Brainstorm Cell Therapeutics, Takara Holdings Inc., and Ge Healthcare.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
2.5. Estimation Methodology
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Regenerative Medicine Is The Emerging Branch Of Medical Science
3.2.2. Use Of Adult Stem Cells Has Been Significant
4. Market Determinants
4.1. Market Driver
4.1.1. Potential Of Stem Cells In Regenerative Medicine
4.1.2. Key To Anti-ageing And Prolonging Life
4.1.3. Increasing R&D Investments In Adult Stem Cell Research
4.1.4. Ease Of Administration
4.1.5. Reduced Risk Of Tissue Rejection In Transplants
4.2. Market Restraints
4.2.1. Safety Issues
4.2.2. Ethical Issues
4.3. Opportunities
4.3.1. Technological Innovations
4.3.2. Emerging Application As A Drug Discovery Tool
4.3.3. Other Promising Applications
4.4. Market Challenges
4.4.1. Stringent Government Regulations
4.4.2. Less Responsiveness In The Developed Economies
5. Market Segmentation
5.1. Market By Products 2018-2026
5.1.1. Adult Stem Cell Market
5.1.1.1. Hematopoietic Stem Cell Market
5.1.1.2. Mesenchymal Stem Cell Market
5.1.1.3. Neural Stem Cell Market
5.1.1.4. Dental Stem Cell Market
5.1.1.5. Umbilical Cord Stem Cell Market
5.1.2. Human Embryonic Stem Cell
5.1.3. Induced Pluripotent Stem Cell Market
5.1.4. Rat Neural Stem Cell Market
5.2. Market By Technology 2018-2026
5.2.1. Stem Cell Acquisition
5.2.1.1. Stem Cell Bone Marrow Market
5.2.1.2. Stem Cell Apheresis Market
5.2.1.3. Umbilical Cord Blood Market
5.2.2. Stem Cell Production
5.2.2.1. Therapeutic Cloning
5.2.2.2. Ivf Stem Cell
5.2.2.3. Stem Cell Culture
5.2.3. Stem Cell Cryopreservation
5.2.4. Stem Cells Expansion And Sub-culture
5.3. Market By Application 2018-2026
5.3.1. Regenerative Medicine
5.3.2. Drug Discovery And Development
6. Key Analytics
6.1. Porter’s Five Forces Analysis
6.1.1. Threat Of New Entrants
6.1.2. Threat Of Substitute Products Or Services
6.1.3. Bargaining Power Of Buyer
6.1.4. Bargaining Power Of Supplier
6.1.5. Intensity Of Competitive Rivalry
6.2. Value Chain Analysis
6.3. Opportunity Matrix
6.4. Key Buying Criteria
6.4.1. High Price
6.4.2. Efficacy
6.4.3. Application And Effectiveness
6.4.4. Accuracy
6.5. Pest Analysis
6.6. History Of Stem Cell
6.7. Patent Analysis
6.7.1. Stem Cell Patent In Asia Pacific
6.8. Regulatory Framework
7. Geographical Analysis
7.1. Asia Pacific (Apac)
7.1.1. India
7.1.2. China
7.1.3. Japan
7.1.4. South Korea
7.1.5. Rest Of Asia Pacific (Roapac)
8. Company Profile
8.1. Competitive Landscape
8.1.1. Market Share Analysis
8.2. Becton Dickinson
8.2.1. Company Overview
8.2.2. Product Portfolio
8.2.3. Scot Analysis
8.2.4. Strategic Initiatives
8.3. Biotime Inc
8.3.1. Company Overview
8.3.2. Product Portfolio
8.3.3. Scot Analysis
8.3.4. Strategic Initiatives
8.4. Brainstorm Cell Therapeutics
8.4.1. Company Overview
8.4.2. Product Portfolio
8.4.3. Scot Analysis
8.4.4. Strategic Initiatives
8.5. Celgene Corporation
8.5.1. Company Overview
8.5.2. Product Portfolio
8.5.3. Scot Analysis
8.5.4. Strategic Initiatives
8.6. Cellular Dynamics International (Holding Company Fujifilm)
8.6.1. Company Overview
8.6.2. Product Portfolio
8.6.3. Scot Analysis
8.6.4. Strategic Initiatives
8.7. Cellular Engineering Technologies Inc.
8.7.1. Company Overview
8.7.2. Product Portfolio
8.7.3. Scot Analysis
8.7.4. Strategic Initiatives
8.8. Corestem Inc
8.8.1. Company Overview
8.8.2. Product Portfolio
8.8.3. Scot Analysis
8.8.4. Strategic Initiatives
8.9. Corning Inc.
8.9.1. Company Overview
8.9.2. Product Portfolio
8.9.3. Scot Analysis
8.9.4. Strategic Initiatives
8.10. Cytori Therapeutics
8.10.1. Company Overview
8.10.2. Product Portfolio
8.10.3. Scot Analysis
8.10.4. Strategic Initiatives
8.11. Fibrocell Science Inc
8.11.1. Company Overview
8.11.2. Product Portfolio
8.11.3. Scot Analysis
8.11.4. Strategic Initiatives
8.12. Ge Healthcare
8.12.1. Company Overview
8.12.2. Product Portfolio
8.12.3. Scot Analysis
8.12.4. Strategic Initiatives
8.13. Kangstem Biotech Ltd
8.13.1. Company Overview
8.13.2. Product Portfolio
8.13.3. Strategic Initiatives
8.14. Stemedica Cell Technologies Inc
8.14.1. Company Overview
8.14.2. Product Portfolio
8.14.3. Strategic Initiatives
8.15. Stryker Corporation
8.15.1. Company Overview
8.15.2. Product Portfolio
8.15.3. Scot Analysis
8.15.4. Strategic Initiatives
8.16. Takara Holdings Inc.
8.16.1. Company Overview
8.16.2. Product Portfolio
8.16.3. Scot Analysis
8.16.4. Strategic Initiatives
8.17. Thermo Fisher
8.17.1. Company Overview
8.17.2. Product Portfolio
8.17.3. Scot Analysis
8.17.4. Strategic Initiatives
8.18. Vericel Corporation (Formerly Aastrom Bioscience)
8.18.1. Company Overview
8.18.2. Product Portfolio
8.18.3. Scot Analysis
8.18.4. Strategic Initiatives
Table List
Table 1 Asia Pacific Stem Cell Market 2018-2026 ($ Million)
Table 2 Asia Pacific Stem Cells Market By Products 2018-2026 ($ Million)
Table 3 Asia Pacific Stem Cell Market In Adult Stem Cell 2018-2026 ($ Million)
Table 4 Asia Pacific Stem Cell Market In Adult Stem Cell By Types 2018-2026 ($ Million)
Table 5 Asia Pacific Adult Stem Cell Market In Hematopoietic Stem Cell 2018-2026 ($ Million)
Table 6 Asia Pacific Adult Stem Cell Market In Mesenchymal Stem Cell 2018-2026 ($ Million)
Table 7 Asia Pacific Adult Stem Cell Market In Neural Stem Cell 2018-2026 ($ Million)
Table 8 Asia Pacific Adult Stem Cell Market In Dental Stem Cell 2018-2026 ($ Million)
Table 9 Asia Pacific Adult Stem Cell Market In Umbilical Cord Stem Cell 2018-2026 ($ Million)
Table 10 Asia Pacific Stem Cell Market In Human Embryonic Stem Cell 2018-2026 ($ Million)
Table 11 Asia Pacific Stem Cells Market In Induced Pluripotent Stem Cell 2018-2026 ($ Million)
Table 12 Asia Pacific Stem Cell Market In Rat Neural Stem Cell 2018-2026 ($ Million)
Table 13 Asia Pacific Stem Cell Market By Technology 2018-2026 ($ Million)
Table 14 Asia Pacific Stem Cell Market In Acquisition By Types 2018-2026 ($ Million)
Table 15 Asia Pacific Stem Cell Market In Acquisition 2018-2026 ($ Million)
Table 16 Asia Pacific Stem Cell Acquisition Market In Bone Marrow By Geography 2018-2026 ($ Million)
Table 17 Asia Pacific Stem Cell Acquisition Market In Cell Apheresis 2018-2026 ($ Million)
Table 18 Asia Pacific Stem Cell Acquisition Market In Umbilical Cord Blood 2018-2026 ($ Million)
Table 19 Asia Pacific Stem Cell Market In Production By Types 2018-2026 ($ Million)
Table 20 Asia Pacific Stem Cell Market In Production 2018-2026 ($ Million)
Table 21 Asia Pacific Stem Cell Production Market In Therapeutic Cloning 2018-2026 ($ Million)
Table 22 Asia Pacific Stem Cell Production Market In Ivf Stem Cell 2018-2026 ($ Million)
Table 23 Asia Pacific Stem Cell Production Market In Stem Cell Culture 2018-2026 ($ Million)
Table 24 Asia Pacific Stem Cell Market In Stem Cell Cryopreservation 2018-2026 ($ Million)
Table 25 Asia Pacific Stem Cell Market In Stem Cell Expansion And Sub-culture 2018-2026 ($ Million)
Table 26 Asia Pacific Stem Cells Market By Application 2018-2026 ($ Million)
Table 27 Asia Pacific Stem Cells Market In Regenerative Medicine 2018-2026 ($ Million)
Table 28 Asia Pacific Stem Cell Market In Drug Discovery And Development 2018-2026 ($ Million)
Table 29 Asia Pacific Stem Cell Market By Country 2018-2026 ($ Million)
Figures List
Figure 1 Asia Pacific Stem Cell Market 2018-2026 ($ Million)
Figure 2 Asia Pacific Stem Cell Market In Adult Stem Cell 2018-2026 ($ Million)
Figure 3 Asia Pacific Adult Stem Cell Market In Hematopoietic Stem Cell 2018-2026 ($ Million)
Figure 4 Asia Pacific Adult Stem Cell Market In Mesenchymal Stem Cell 2018-2026 ($ Million)
Figure 5 Asia Pacific Adult Stem Cell Market In Neural Stem Cell 2018-2026 ($ Million)
Figure 6 Asia Pacific Adult Stem Cell Market In Dental Stem Cell 2018-2026 ($ Million)
Figure 7 Asia Pacific Adult Stem Cell Market In Umbilical Cord Stem Cell 2018-2026 ($ Million)
Figure 8 Asia Pacific Stem Cell Market In Human Embryonic Stem Cell 2018-2026 ($ Million)
Figure 9 Asia Pacific Stem Cells Market In Induced Pluripotent Stem Cell 2018-2026 ($ Million)
Figure 10 Asia Pacific Stem Cell Market In Rat Neural Stem Cell 2018-2026 ($ Million)
Figure 11 Asia Pacific Stem Cell Market In Acquisition 2018-2026 ($ Million)
Figure 12 Asia Pacific Stem Cell Acquisition Market In Bone Marrow 2018-2026 ($ Million)
Figure 13 Asia Pacific Stem Cell Acquisition Market In Apheresis 2018-2026 ($ Million)
Figure 14 Asia Pacific Stem Cell Acquisition Market In Umbilical Cord Blood 2018-2026 ($ Million)
Figure 15 Asia Pacific Stem Cell Market In Production 2018-2026 ($ Million)
Figure 16 Asia Pacific Stem Cell Production Market In Therapeutic Cloning 2018-2026 ($ Million)
Figure 17 Asia Pacific Stem Cell Production Market In Ivf Stem Cell 2018-2026 ($ Million)
Figure 18 Asia Pacific Stem Cell Production Market In Stem Cells Culture 2018-2026 ($ Million)
Figure 19 Asia Pacific Stem Cell Market In Stem Cells Cryopreservation 2018-2026 ($ Million)
Figure 20 Asia Pacific Stem Cell Market In Stem Cell Expansion And Sub-culture 2018-2026 ($ Million)
Figure 21 Asia Pacific Stem Cells Market In Regenerative Medicine 2018-2026 ($ Million)
Figure 22 Asia Pacific Stem Cell Market In Drug Discovery And Development 2018-2026 ($ Million)
Figure 23 India Stem Cell Market 2018-2026 ($ Million)
Figure 24 China Stem Cell Market 2018-2026($ Million)
Figure 25 Japan Stem Cell Market 2018-2026 ($ Million)
Figure 26 South Korea Stem Cell Market 2018-2026 ($ Million)
Figure 27 Rest Of Apac Stem Cell Market 2018-2026($ Million)
Figure 28 Stem Cell Market Share Analysis Of Key Players 2017 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report